Market of Bulk Drugs and Intermediate for Pharmaceuticals 2020

Language:
Japanese
Product Code No:
C62119400
Issued In:
2020/12
#of Pages:
297
Publication Cycle:
Annual
Format:
PDF

Price

120,000 yen ($777.05)
(excluding consumption tax)
240,000 yen ($1,554.10)
(excluding consumption tax)
360,000 yen ($2,331.15)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.43 yen , 2024/04/16 Japan)
*Scope of Each License Type

Coverage: (Product/service)

Bulk Drugs and Intermediate for Pharmaceuticals

Research Target:

Companies of Bulk Drugs and Intermediate for Pharmaceuticals, outsourcing companies, pharmaceutical contracted manufacturers and contractors

Research Content:

I   Market Trend Analysis of Bulk Drugs and Intermediate for Pharmaceuticals

  1. Transition of Market Size of Bulk Drugs and Intermediate for Pharmaceuticals (FY2015 - FY2019)
  2. Trends of Companies developing Bulk Drugs and Intermediate for Pharmaceuticals
  3. Problems and Challenges for Companies developing Bulk Drugs and Intermediate for Pharmaceuticals
  4. Market Outlook of Bulk Drugs and Intermediate for Pharmaceuticals
  5. Estimated Market Size of Bulk Drugs and Intermediate for Pharmaceuticals (FY2020 - FY2023)

II   Analysis of Market Strategies Taken by Leading Developers of Bulk Drugs and Intermediate for Pharmaceuticals

  1. Business Outline
  2. Recent Requests from Manufacturers that Developers Accept Orders from
  3. Trend of R&D
  4. Trend of Production and Quality Management
  5. Sales Trends
  6. Future Market Strategies
  7. Promising Contractor Sectors and Business/Estimated Demands

III   Strategies of Contract Manufacturing of Bulk Drugs and Intermediate for Pharmaceuticals

  1. Thoughts and Business Positioning towards Outsourcing of Bulk Drugs and Intermediate for Pharmaceuticals
  2. What to Outsource in Business of Bulk Drugs and Intermediate for Pharmaceuticals
  3. Criteria to Select Outsourcing Companies in the Business of Bulk Drugs and Intermediate for Pharmaceuticals
  4. Challenges and Problems in Outsourcing Business of Bulk Drugs and Intermediate for Pharmaceuticals
  5. Thoughts and Directions in Outsourcing of Bulk Drugs and Intermediate for Pharmaceuticals
  6. Products that want to Outsource in Bulk Drugs and Intermediate for Pharmaceuticals
  7. Criteria, Services, Facilities, and Knowledge Needed in Outsourcing Companies for Bulk Drugs and Intermediate for Pharmaceuticals
  8. Potential of Outsourcing Business for Bulk Drugs and Intermediate for Pharmaceuticals

IV   Market Strategies Taken by Leading Companies of Bulk Drugs and Intermediate for Pharmaceuticals

  • Ube Industries, Ltd.
  • API Corporation
  • KOA SHOJI HOLDINGS CO., LTD.
  • KNC Laboratories Co., Ltd.
  • SANYO FINE CO., LTD.
  • SHIRATORI Pharmaceutical Co., Ltd.
  • SUMITOMO CHEMICAL COMPANY, LIMITED
  • SEKISUI MEDICAL CO., LTD.
  • Central Glass Co., Ltd.
  • DAIKIN INDUSTRIES, LTD.
  • Daito Pharmaceutical Co., Ltd.
  • TOYOBO CO., LTD.
  • Nissan Chemical Corporation
  • Hamari Chemicals, Ltd.
  • NARD INSTITUTE, LTD./NARD CHEMICALS, LTD.
  • FUJIFILM Wako Pure Chemical Corporation

V   Profiles of Leading Companies of Bulk Drugs and Intermediate for Pharmaceuticals

87 enterprises

Price

written in Japanese
120,000 yen ($777.05)
(excluding consumption tax)
240,000 yen ($1,554.10)
(excluding consumption tax)
360,000 yen ($2,331.15)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 154.43 yen , 2024/04/16 Japan)
*Scope of Each License Type